Paul J. Isaac Purchases 23,299 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac purchased 23,299 shares of Stereotaxis stock in a transaction on Thursday, March 6th. The shares were acquired at an average cost of $1.81 per share, for a total transaction of $42,171.19. Following the completion of the transaction, the director now owns 49,066 shares of the company’s stock, valued at $88,809.46. This represents a 90.42 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Stereotaxis Trading Down 5.3 %

Shares of STXS stock opened at $1.77 on Tuesday. The firm has a market capitalization of $149.97 million, a PE ratio of -6.32 and a beta of 1.54. Stereotaxis, Inc. has a fifty-two week low of $1.66 and a fifty-two week high of $3.29. The firm’s 50 day simple moving average is $2.26.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of STXS. Charles Schwab Investment Management Inc. lifted its position in Stereotaxis by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after buying an additional 15,491 shares in the last quarter. State Street Corp raised its stake in shares of Stereotaxis by 5.7% during the third quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after purchasing an additional 36,518 shares during the period. Jane Street Group LLC raised its stake in shares of Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after purchasing an additional 6,313 shares during the period. Barclays PLC raised its stake in shares of Stereotaxis by 449.9% during the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock valued at $208,000 after purchasing an additional 83,412 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Stereotaxis by 7.2% during the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock valued at $2,840,000 after purchasing an additional 93,253 shares during the period. 45.35% of the stock is owned by institutional investors and hedge funds.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.